Authors:
Hainsworth, JD
Burris, HA
Calvert, SW
Willcutt, NT
Scullin, DC
Bramham, J
Greco, FA
Citation: Jd. Hainsworth et al., Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: A phase II trial of the Minnie Pearl Cancer Research Network, CANCER INV, 19(4), 2001, pp. 335-339
Authors:
Burris, HA
Hainsworth, JD
Erland, JB
Morrissey, LH
Kalman, LA
Hon, JK
Scullin, DC
Smith, SW
Greco, FA
Citation: Ha. Burris et al., Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer, SEMIN ONCOL, 27(1), 2000, pp. 9-13
Authors:
Hainsworth, JD
Burris, HA
Morrissey, LH
Litchy, S
Scullin, DC
Bearden, JD
Richards, P
Greco, FA
Citation: Jd. Hainsworth et al., Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma, BLOOD, 95(10), 2000, pp. 3052-3056
Authors:
Hainsworth, JD
Burris, HA
Erland, JB
Morrissey, LH
Meluch, AA
Kalman, LA
Hon, JK
Scullin, DC
Smith, SW
Greco, FA
Citation: Jd. Hainsworth et al., Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma, CANCER, 85(6), 1999, pp. 1269-1276